Cedars-Sinai Medical Center - Archive zaldy-tan-85936
Filter by year
2026
August
14,
2026
|
09:00 AM
America/Los_Angeles
Prevention recently interviewed Zaldy Tan, MD, MPH, medical director of the Jona Goldrich Center for Alzheimer’s and Memory Disorders and director of the Memory and Healthy Aging Program at Cedars-Sinai, about the important distinctions between …
Read more
April
06,
2026
|
06:30 AM
America/Los_Angeles
When Carrie Elam wakes up at 6 a.m., she begins her day with leg exercises in bed before stepping outside to meditate in her expansive backyard perched above Baldwin Hills. From there, she can see across Los Angeles—from Century City to Downtown—as …
Read more
2025
April
25,
2025
|
09:00 AM
America/Los_Angeles
Prevention recently interviewed Zaldy Tan, MD, MPH, medical director of the Jona Goldrich Center for Alzheimer’s and Memory Disorders at Cedars-Sinai, about the role of genetics in the development of Alzheimer’s disease—the most common form of …
Read more
2023
November
09,
2023
|
09:00 AM
America/Los_Angeles
“Our America: Unforgettable,” an hourlong special streaming on ABC7.com, features Zaldy Tan, MD, MPH, medical director of the Jona Goldrich Center for Alzheimer’s and Memory Disorders and the Carmen and Louis Warschaw Chair …
Read more
August
22,
2023
|
06:00 AM
America/Los_Angeles
In July, the first direct-to-consumer blood test designed to assess a user’s risk for developing Alzheimer’s disease hit the market. The test, which has not undergone Food and Drug Administration (FDA) review, measures the level of a protein called …
Read more
August
18,
2023
|
09:00 AM
America/Los_Angeles
ABC 7 recently interviewed Zaldy Tan, MD, MPH, medical director of the Jona Goldrich Center for Alzheimer’s and Memory Disorders in Cedars-Sinai’s Department of Neurology, about new research that revealed California has a high rate of older adults …
Read more
July
27,
2023
|
09:00 AM
America/Los_Angeles
NPR recently interviewed Zaldy Tan, MD, MPH, medical director of the Jona Goldrich Center for Alzheimer’s and Memory Disorders in the Department of Neurology at Cedars-Sinai, about lecanemab—the new Alzheimer’s medication that’s now fully approved …
Read more